Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (541-550 of 548) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 548 results.
The Journal of Pharmacy and Pharmacology|November 8, 2001
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's diseaseN S Perry, P J Houghton, J Sampson, et al.
Journal of the American Chemical Society|September 29, 2022
Reaction of Thiosulfate Dehydrogenase with a Substrate Mimic Induces Dissociation of the Cysteine Heme Ligand Giving Insights into the Mechanism of Oxidative CatalysisLeon P Jenner, Jason C Crack, Julia M Kurth, et al.
Neuropharmacology|June 1, 1996
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivoS Urwyler, E Campbell, G Fricker, et al.
Gene Therapy|May 18, 1999
High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5M K Howard, T Kershaw, B Gibb, et al.
Nanotechnology|May 14, 2020
His/Met heme ligation in the PioA outer membrane cytochrome enabling light-driven extracellular electron transfer by Rhodopseudomonas palustris TIE-1Dao-Bo Li, Marcus J Edwards, Anthony W Blake, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's diseaseK Shiosaki, P Jenner, K E Asin, et al.
Neurologia (Barcelona, Spain)|May 14, 2005
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]A Castro, F Valldeoriola, G Linazasoro, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 55

Showing results (541-550 of 548) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 548 results.
The Journal of Pharmacy and Pharmacology|November 8, 2001
In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's diseaseN S Perry, P J Houghton, J Sampson, et al.
Journal of the American Chemical Society|September 29, 2022
Reaction of Thiosulfate Dehydrogenase with a Substrate Mimic Induces Dissociation of the Cysteine Heme Ligand Giving Insights into the Mechanism of Oxidative CatalysisLeon P Jenner, Jason C Crack, Julia M Kurth, et al.
Neuropharmacology|June 1, 1996
Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-methyl-D-aspartate receptor antagonists--II. Pharmacological characterization in vivoS Urwyler, E Campbell, G Fricker, et al.
Gene Therapy|May 18, 1999
High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5M K Howard, T Kershaw, B Gibb, et al.
Nanotechnology|May 14, 2020
His/Met heme ligation in the PioA outer membrane cytochrome enabling light-driven extracellular electron transfer by Rhodopseudomonas palustris TIE-1Dao-Bo Li, Marcus J Edwards, Anthony W Blake, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's diseaseK Shiosaki, P Jenner, K E Asin, et al.
Neurologia (Barcelona, Spain)|May 14, 2005
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]A Castro, F Valldeoriola, G Linazasoro, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 55